Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases.
Jia-Run LinDuan-Duan HanWei WeiQin ZengZi-Xuan RongXue BaiYan-Pei ZhangJian WangXiao-Ting CaiXu-Guang RaoSi-Cong MaZhong-Yi DongPublished in: Cancer research (2024)
Individuals with systemic inflammatory diseases derive chemoprotective benefits from aspirin and statins, providing a precision cancer prevention approach to address the personal and public challenges posed by cancer.